Ethical Use of Synthetic Data in Generative AI: Benefits and Boundaries
Susannah Greenwood
Susannah Greenwood

I'm a technical writer and AI content strategist based in Asheville, where I translate complex machine learning research into clear, useful stories for product teams and curious readers. I also consult on responsible AI guidelines and produce a weekly newsletter on practical AI workflows.

8 Comments

  1. Steven Hanton Steven Hanton
    March 17, 2026 AT 06:21 AM

    Synthetic data is a game-changer, no doubt. But I’ve seen too many teams treat it like a magic bullet-generate, deploy, forget. The real win isn’t just in privacy or scale; it’s in the discipline to validate rigorously. Duke’s 85% accuracy threshold isn’t arbitrary-it’s a baseline for ethical responsibility. If you’re not measuring KL divergence, JS distance, and subgroup fairness metrics, you’re not building AI. You’re building blind spots with better packaging.

    And yes, hybrid approaches work. 60/40 real-to-synthetic isn’t just a suggestion. It’s a hedge against the unknown. Rare events don’t show up in synthetic data because they’re rare. But they still happen. Real data reminds us that reality doesn’t follow a distribution curve-it defies it.

  2. Kristina Kalolo Kristina Kalolo
    March 17, 2026 AT 13:09 PM

    Just read this entire post and had to pause. The part about bias amplification hit hard. I work in fintech and we started using synthetic data last year to train fraud models. We didn’t catch the gender skew until a customer got denied a loan because her transaction pattern ‘didn’t match’-turns out, it was because the synthetic data was trained on male-dominated spending logs. We had to roll back, retrain, and add manual audits. Synthetic data isn’t neutral. It’s a mirror. And if you don’t check the reflection, you’re just reinforcing the cracks.

  3. ravi kumar ravi kumar
    March 17, 2026 AT 17:37 PM

    In India, we’re still struggling to get access to real medical data-even for public health research. Synthetic data is the only way forward for small labs like mine. But you’re right about the global divide. Our models trained on U.S. synthetic data failed miserably on local patients. Different diets, different genetics, different access to care. We’re not just building AI. We’re building colonial tools if we don’t adapt. We started generating our own synthetic data from local hospital records (with consent) and saw a 31% improvement in accuracy. It’s not perfect, but it’s honest. And that’s a start.

  4. Akhil Bellam Akhil Bellam
    March 17, 2026 AT 19:00 PM

    Oh, please. You’re all acting like synthetic data is some kind of ethical breakthrough. It’s just data laundering with a PhD. You hide behind ‘statistical fidelity’ while your model discriminates against Black patients, then blame the ‘original data’ like you’re not the ones who chose to train on it. And don’t get me started on ‘provenance labeling’-like slapping a sticker on a toxic waste barrel makes it safe. The EU AI Act? A PR stunt. Real accountability? That’s when the person who generated the data gets sued when someone dies because their AI missed a tumor. Until then? It’s all theater. And theater is expensive. And boring.

  5. Amber Swartz Amber Swartz
    March 17, 2026 AT 22:21 PM

    OKAY BUT CAN WE TALK ABOUT HOW SOME PEOPLE ARE JUST USING SYNTHETIC DATA TO AVOID REAL WORK?? I MEAN, COME ON. You’re telling me a startup in Tennessee built a diabetic retinopathy detector with synthetic data and now they’re on the front page of TechCrunch? Meanwhile, actual clinicians are drowning in real patient charts and NO ONE IS PAYING THEM TO DO THE HARD THING? This isn’t innovation. It’s performative efficiency. And the academic papers? 17% lying about data sources?? That’s not just dishonest-that’s a whole generation of researchers learning to game the system. And we’re rewarding them with citations. I’m sick of it.

  6. Robert Byrne Robert Byrne
    March 19, 2026 AT 08:47 AM

    You’re all missing the point. The real issue isn’t bias or labeling or even cost. It’s that synthetic data is being used as a *shield*. Companies don’t use it because it’s better-they use it because it lets them dodge legal liability. ‘Oh, we didn’t use real patient data!’ Cool. But if your model misdiagnoses someone because it never learned what a real diabetic foot ulcer looks like, who’s liable? The data scientist? The vendor? The hospital? No one. And that’s the whole point. It’s legal obfuscation dressed up as innovation. The EU’s provenance labeling is the first step toward accountability. But until we start holding individuals responsible-not corporations, not tools, not ‘the system’-this whole thing is a Ponzi scheme with a dataset.

  7. Tia Muzdalifah Tia Muzdalifah
    March 20, 2026 AT 09:19 AM

    honestly i think synthetic data is kinda wild? like, imagine creating fake patient records that are *better* than real ones because they’re balanced and clean? but then u realize… oh wait, it’s still just copying biases from real data. and then u see the 22% drop in accuracy for southeast asian patients and u’re like… huh. we built this whole thing on a lie? and now we’re calling it ‘ethical’? i dunno. i’m just here for the tech, but also… yikes.

  8. Zoe Hill Zoe Hill
    March 20, 2026 AT 09:34 AM

    I just want to say thank you for writing this. It’s so clear and thoughtful. I’ve been working on a project using synthetic data for mental health screening, and I was so worried about bias. The part about hybrid datasets gave me hope. We’re now using 70% real, 30% synthetic-and we’re tagging every synthetic sample. It’s more work, but it feels right. Also, the NIST framework? Lifesaver. I printed it out. It’s on my desk. Small steps, right? We’re not perfect, but we’re trying.

Write a comment